Name | Grade | Attribution |
---|---|---|
Anaphylaxis | 3 | Unrelated |
Back pain | 3 | Unrelated |
Gastrointestinal disorders ‐ Other, specify | 3 | Unrelated |
Lung Infection | 3 | Unrelated |
Neutrophil count decreased | 2 | Possible |
Syncope | 3 | Unlikely |
Urinary tract infection | 3 | Unrelated |
After a median follow‐up of 22 months, adverse events for radium‐223 plus enzalutamide versus enzalutamide alone are reported.